Medical Researchers Want Up To Five Years Exclusivity For Clinical Trial Data Derived From Volunteers

A year ago, we wrote about how TPP's requirement for "data exclusivity" risked undermining one of science's fundamental principles: that facts cannot be owned. Data exclusivity is just the latest attempt by Big Pharma to extend its...

Continue reading...